Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLucia Del Mastro, A Parisi, Mario Giuliano et al.|The Lancet Oncology|2022Cited by 50
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in ItalyFrancesco Cognetti, Sandro Barni, Riccardo Masetti et al.|npj Breast Cancer|2021Cited by 29